Phase I/II trial of ELI 001 for the treatment of Cervical intraepithelial neoplasia or Vulvar intraepithelial neoplasia
Latest Information Update: 12 Jul 2019
At a glance
- Drugs VED 001 (Primary)
- Indications Cervical intraepithelial neoplasia; Vulvar intraepithelial neoplasia
- Focus Adverse reactions; Therapeutic Use
- 12 Jul 2019 New trial record